Eculizumab Add-On Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study（ETA/PETA-NMOSD Study）

by palligoelme@gmail.com | Feb 13, 2026 | Clinical Trials

​ Conditions: Neuromyelitis Optica Spectrum Disorder Attack Interventions: Drug: Eculizumab+IVMP; Drug: IVIG+IVMP; Drug: IVMP Sponsors: Chinese PLA General Hospital Not yet recruiting Conditions: Neuromyelitis Optica Spectrum Disorder Attack Interventions: Drug:...

Supporting Caregivers Following Mental Health Emergency Department Visits

by palligoelme@gmail.com | Feb 13, 2026 | Clinical Trials

​ Conditions: Caregiver Participation; Emergency Department Presentation; Safety Plan Interventions: Behavioral: Telephone Calls; Behavioral: Automatic MyChart Messages Sponsors: Ann & Robert H Lurie Children’s Hospital of Chicago; Health Resources and...

Total Hip Arthroplasty Versus Bipolar Hemiarthroplasty for Treatment of Intracapsular Displaced Fracture Neck Femur in Elderly Active Patients

by palligoelme@gmail.com | Feb 13, 2026 | Clinical Trials

​ Conditions: Displaced Fracture Neck Femur; Total Hip Arthroplasty (THA); Bipolar Hemiarthroplasty; Elderly Active Patients Interventions: Procedure: Total Hip Arthroplasty; Procedure: Bipolar Hemiarthroplasty Sponsors: Al-Azhar University Completed Conditions:...

Prophylactic Use of APRV Before Extubation in Morbidly Obese Patients After Cardiac Surgery.

by palligoelme@gmail.com | Feb 13, 2026 | Clinical Trials

​ Conditions: Morbid Obesity in Cardiac Surgery Patients; Postoperative Respiratory Dysfunction; Mechanical Ventilation Strategies Interventions: Device: Airway Pressure Release Ventilation (APRV); Device: Conventional Lung-Protective Mechanical Ventilation Sponsors:...

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: SRN001; Drug: 0.9% sodium chloride (normal saline) Sponsors: siRNAgen Therapeutics Inc. Recruiting Conditions: Idiopathic Pulmonary Fibrosis Interventions: Drug: SRN001; Drug: 0.9% sodium chloride...

Effect of IMB Model-Based Education for Women With Menopausal Hot Flashes

by palligoelme@gmail.com | Feb 12, 2026 | Clinical Trials

​ Conditions: Menopausal Hot Flashes Interventions: Behavioral: IMB Model-Based Education Program Sponsors: Marmara University Active, not recruiting Conditions: Menopausal Hot Flashes Interventions: Behavioral: IMB Model-Based Education Program Sponsors: Marmara...